1. Nakamoto H (2005) Encapsulating Peritoneal Sclerosis—a clinician 0 s approach to diagnosis and medical treatment. Perit Dial Int 25(Suppl 4):30–38
2. Vlijm A, Stoker J, Bipat S, Spijkerboer AM, Phoa SS, Maes R, Struijk DG, Krediet RT (2009) Computed tomographic findings characteristic for encapsulating peritoneal sclerosis: a case-control study. Perit Dial Int 29(5):517–522
3. Kawanishi H, Kawaguchi Y, Fukui H, Hara S, Imada A, Kubo H, Kin M, Nakamoto M, Ohira S, Shoji T (2004) Encapsulating peritoneal sclerosis in Japan: a prospective, controlled, multicenter study. Am J Kidney Dis 44(4):729– 737
4. Korte MR, Yo M, Betjes M, Fieren MW, van Saase JC, Boer WH, Weimar W, Zietse R (2007) Increasing inci- dence of severe encapsulating peritoneal sclerosis after kidney transplantation. Nephrol Dial Transplant 22(8): 2412–2414 
5. Ya  ̃ez-Mo M, Lara-Pezzi E, Selgas R, Ramirez-Huesca M, Dominguez-Jimenez C, Jimenez-Heffernan J, Aguilera A, Sanchez-Tomero JA, Bajo MA, Alvarez V, Castro MA, del Peso G, Cirujeda A, Gamallo C, Sanchez-Madrid F, Lopez- Cabrera M (2003) Peritoneal dialysis and epithelial-to- mesenchymal transition of mesothelial cells. N Engl J Med 348(5):403–413
6. Park SH, Kim YL, Lindholm B (2008) Experimental encapsulating peritoneal sclerosis models: pathogenesis and treatment. Perit Dial Int 28(Suppl 5):S21–S28
7. Kawanishi H, Moriishi M, Ide K, Dohi K (2008) Recom- mendation of the surgical option for treatment of encapsulating peritoneal sclerosis. Perit Dial Int 28(Suppl 3): 205–210
8. Van Bommel E, Hendriksz T, Huiskes A, Zeegers A (2006) Brief communication: tamoxifen therapy for non-malignant retroperitoneal fibrosis. Ann Intern Med 144(2):101–106
9. Guest S (2009) Tamoxifen therapy for encapsulating peritoneal sclerosis: mechanism of action and update on clinical experiences. Perit Dial Int 29(3):252–255